Your session is about to expire
← Back to Search
Spinal Stimulation and Exercise for Spinal Cord Injury
Study Summary
This trialtests if spinal cord stimulation combined with physical therapy can improve motor functions in patients with spinal cord injury.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have uncontrolled high blood pressure or serious heart, lung, or blood clotting issues.I have a condition that could affect my ability to participate in leg exercises or tests.I understand the instructions given in the study.I am between 21 and 70 years old.I have nerve damage, such as from diabetes.I have a heart or muscle condition that stops me from fully joining in physical therapy.I can safely participate in all study tests as determined by my doctor.My doctor has approved me for walking training.I have a rheumatic disease like rheumatoid arthritis or lupus.I have had fractures due to low energy, before or after a spinal injury.I have had a spinal cord injury above my waist for over a year.I have trouble with daily activities due to leg function issues.My spinal cord injury is due to an autoimmune disease.My cancer is currently active.My health is stable, and I don't have heart or lung disease that would stop me from doing leg exercises.I have been diagnosed with depression or anxiety based on specific questionnaires.I can perform simple tasks when guided.I can attend up to 5 physical therapy sessions weekly.I have osteoporosis and am on medication for it.I have a history of a neurological condition like stroke or MS.
- Group 1: Transcutaneous spinal stimulation & Physical therapy
- Group 2: Physical therapy only
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals have been admitted to this clinical experiment?
"That is accurate. According to clinicaltrials.gov, this medical trial was originally posted on February 28th 2018 and has been actively seeking participants since then. 10 individuals are needed at 1 site for the experiment to be successful."
Are applicants aged 25 and older being considered for this clinical trial?
"The study's requirements state that eligible participants must be between 21 and 70 years old. There are 37 clinical trials for individuals aged 18 or younger, and an additional 307 studies recruiting patients over the age of 65."
Could I qualify to be a participant in this medical experiment?
"This trial is enrolling a maximum of 10 individuals with spinal cord injuries between 21 and 70 years old."
Have applications for participation in this experiment been opened yet?
"According to clinicaltrials.gov, this research study is still in the process of recruiting patients; it was first listed on February 28th 2018 and most recently edited on November 14th 2022."
What is the prime objective of this clinical experiment?
"The primary assessment tool employed in this trial over the 8-11 month timeframe is Neuromuscular Recovery Scale. Secondary measures include Neurogenic Bowel Dysfunction Score, which assesses background parameters and impact of bowel management on quality of life; Electromyography recording to measure muscle and nerve function; and a validated self-report questionnaire for assessing bladder symptoms known as the Neurogenic Bladder Symptom Score."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger